Regulation of Tyrosinase mRNA in Mouse Melanoma Cells by α -Melanocyte–Stimulating Hormone
Journal of Investigative Dermatology, ISSN: 0022-202X, Vol: 107, Issue: 5, Page: 689-693
1996
- 13Citations
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations13
- Citation Indexes13
- 13
- CrossRef9
- Captures2
- Readers2
Article Description
Cloudman S-91 mouse melanoma cells respond to α -melanocyte–stimulating hormone) by demonstrating marked increase in tyrosinase activity (O-diphenol-O 2 oxidoreductase EC 1.14.18 1). This increase is the result of increased levels of tyrosinase mRNA with a subsequent increased in tyrosinase abundance. Our studies were carried out to determine the effect of melanocyte-stimulating hormone on tyrosinase gene transcription and to measure the kinetics of the hormone–induced increase in tyrosinase mRNA. When melanoma cells were exposed continuously to melanocyte-stimulating hormone for 6 d, a large but transient increase in both tyrosinase mRNA abundance and enzyme activity were observed. The maximum increase in tyrosinase mRNA occurred 60 h after melanocyte-simulating hormone stimulation and was followed by decline in message levels even though cells were continuously exposed to hormone. Results of nuclear run-off transcription assays showed that melanocyte-stimulating hormone caused a slow increase in the rate of transcription of the tyrosinase gene with a maximal 6-fold stimulation occurring at 48 h. In cells treated with the ribonucleic acid synthesis inhibitor, 5,6-dichloro-1- β -D-ribofuranosyl-benzimidazole, tyrosinase mRNA levels decayed with a half-life of 4–5 h. This decay rate was unaffected by treatment of cells with melanocyte-stimulating hormone, indicating that the hormone does not act to stabilize tyrosinase ribonucleic acid, inhibition of protein synthesis by treatment with cycloheximide had no effect on the melanocyte-stimulating hormone-induced increase in tyrosinase messenger ribonucleic acid levels suggesting that ongoing protein synthesis is not required for, at least, the initial stimulation of tyrosinase gene transcription by melanocyte-stimulating hormone.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022202X15427241; http://dx.doi.org/10.1111/1523-1747.ep12365578; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0029827806&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8875950; https://linkinghub.elsevier.com/retrieve/pii/S0022202X15427241; https://dx.doi.org/10.1111/1523-1747.ep12365578
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know